Cormorant Asset Management »

Boundless Bio shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.5M 1.0M 2.50

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Parabilis Medicines
Rapport Therapeutics (RAPP)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
Eyepoint Com New (EYPT)
Alumis (ALMS)
Abivax Sa Sponsored Ads (ABVX)
Dianthus Therapeutics (DNTH)
Bright Minds Biosciences Com New (DRUG)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Bioage Labs (BIOA)
Oruka Therapeutics (ORKA)
Adlai Nortye Sponsored Ads (ANL)

View all positions for Cormorant Asset Management

Top funds holding Boundless Bio

Arch Venture Corp
FMR
Tang Capital Management
ADAR1 Capital Management
Cormorant Asset Management
Vanguard Capital Management
Wellington Management Company
Millennium Management
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Stonepine Capital Management
Acadian Asset Management

View all funds holding Boundless Bio